Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephritis, Interstitial | 2 | 2023 | 76 | 1.660 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2024 | 787 | 1.580 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2024 | 60 | 0.950 |
Why?
|
| Electrolytes | 1 | 2022 | 68 | 0.860 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 183 | 0.810 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 321 | 0.690 |
Why?
|
| Kidney Diseases | 1 | 2022 | 692 | 0.580 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1366 | 0.460 |
Why?
|
| Agrochemicals | 2 | 2023 | 16 | 0.460 |
Why?
|
| Ceramides | 1 | 2013 | 95 | 0.450 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 305 | 0.360 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2024 | 67 | 0.230 |
Why?
|
| Hyperinsulinism | 1 | 2024 | 85 | 0.230 |
Why?
|
| Kidney | 2 | 2023 | 2147 | 0.230 |
Why?
|
| Paraquat | 1 | 2022 | 19 | 0.220 |
Why?
|
| Cations | 1 | 2022 | 62 | 0.220 |
Why?
|
| Protein Sorting Signals | 1 | 2022 | 44 | 0.210 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2022 | 11 | 0.210 |
Why?
|
| Sirtuin 3 | 1 | 2021 | 38 | 0.190 |
Why?
|
| Peritoneal Dialysis | 1 | 2023 | 125 | 0.190 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 309 | 0.190 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2022 | 347 | 0.180 |
Why?
|
| Reperfusion Injury | 1 | 2021 | 145 | 0.180 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2020 | 107 | 0.180 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 136 | 0.180 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 587 | 0.180 |
Why?
|
| Mice | 6 | 2023 | 34498 | 0.150 |
Why?
|
| Coronary Angiography | 1 | 2020 | 598 | 0.150 |
Why?
|
| Renal Dialysis | 1 | 2024 | 945 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 610 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 2595 | 0.130 |
Why?
|
| Mitochondria | 3 | 2022 | 1284 | 0.130 |
Why?
|
| Sphingosine | 1 | 2013 | 55 | 0.120 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 987 | 0.120 |
Why?
|
| Sphingolipids | 1 | 2013 | 38 | 0.110 |
Why?
|
| DNA Fragmentation | 1 | 2013 | 198 | 0.110 |
Why?
|
| Animals | 6 | 2023 | 59552 | 0.110 |
Why?
|
| Culture Media | 1 | 2013 | 319 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 4317 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 739 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 6942 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2013 | 448 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1237 | 0.090 |
Why?
|
| Humans | 8 | 2024 | 261598 | 0.080 |
Why?
|
| Autophagy | 1 | 2013 | 927 | 0.070 |
Why?
|
| Risk Factors | 1 | 2023 | 17531 | 0.070 |
Why?
|
| Female | 5 | 2024 | 142025 | 0.070 |
Why?
|
| Male | 4 | 2023 | 123010 | 0.070 |
Why?
|
| Child | 2 | 2023 | 29158 | 0.070 |
Why?
|
| Cryoelectron Microscopy | 1 | 2024 | 243 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2024 | 521 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2024 | 37921 | 0.050 |
Why?
|
| Superoxides | 1 | 2021 | 211 | 0.050 |
Why?
|
| Leucine | 1 | 2022 | 352 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2020 | 137 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 15694 | 0.040 |
Why?
|
| Fibrosis | 1 | 2022 | 793 | 0.040 |
Why?
|
| Podocytes | 1 | 2020 | 120 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 417 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2022 | 747 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 14551 | 0.040 |
Why?
|
| Estradiol | 1 | 2021 | 749 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2022 | 1489 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 764 | 0.040 |
Why?
|
| Insulin | 1 | 2022 | 1455 | 0.030 |
Why?
|
| Testosterone | 1 | 2021 | 621 | 0.030 |
Why?
|
| DNA | 1 | 2024 | 2693 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2020 | 717 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 2317 | 0.030 |
Why?
|
| Critical Illness | 1 | 2020 | 714 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2022 | 5710 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 4143 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 14290 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 5049 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2020 | 6873 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 4367 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 7226 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2020 | 5544 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 77992 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 70121 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 86223 | 0.010 |
Why?
|